Preoperative Glycosylated Hemoglobin A1C Impacts Long‐Term Outcomes Following Curative‐Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors

Documenti analoghi

• Insulin‐Dependence and Survival in Pancreatic Neuroendocrine Tumors: Results From the US‐NTSG Group
  di: Muhammad Bilal Mirza, et al.
  Pubblicazione: (2026)
• Development and Validation of a Predictive Risk Score for Blood Transfusion in Patients Undergoing Curative‐Intent Surgery for Intrahepatic Cholangiocarcinoma
  di: Giovanni Catalano, et al.
  Pubblicazione: (2024)
• A Reassessment of the Clinical Utility of 68Ga‐DOTATATE PET/CT in Patients With Gastroenteropancreatic Neuroendocrine Tumors
  di: Orjola Prela, et al.
  Pubblicazione: (2025)
• Preoperative platelet count as an independent predictor of long‐term outcomes among patients undergoing resection for intrahepatic cholangiocarcinoma
  di: Odysseas P. Chatzipanagiotou, et al.
  Pubblicazione: (2024)
• Recurrence After Gallbladder Cancer Resection: Prognostic Impact of CA19‐9 and CEA Levels at Baseline and During Surveillance
  di: Diamantis I. Tsilimigras, et al.
  Pubblicazione: (2025)